These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39044519)

  • 1. Performance of Fully-Automated High-Throughput Plasma Biomarker Assays for Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subjects.
    Giuffrè GM; Quaranta D; Vita MG; Costantini EM; Citro S; Carrozza C; De Ninno G; Calabresi P; Marra C
    J Prev Alzheimers Dis; 2024; 11(4):1073-1078. PubMed ID: 39044519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer's disease: a real-world study.
    Cecchetti G; Agosta F; Rugarli G; Spinelli EG; Ghirelli A; Zavarella M; Bottale I; Orlandi F; Santangelo R; Caso F; Magnani G; Filippi M
    J Neurol; 2024 Oct; 271(10):6739-6749. PubMed ID: 39174818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer's Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms.
    Dakterzada F; Cipriani R; López-Ortega R; Arias A; Riba-Llena I; Ruiz-Julián M; Huerto R; Tahan N; Matute C; Capetillo-Zarate E; Piñol-Ripoll G
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the potential of fully automated LUMIPULSE G plasma assays for detecting Alzheimer's disease pathology.
    Silva-Spínola A; Leitão MJ; Nadal A; Le Bastard N; Santana I; Baldeiras I
    Alzheimers Res Ther; 2024 Mar; 16(1):51. PubMed ID: 38454502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.
    Albani D; Marizzoni M; Ferrari C; Fusco F; Boeri L; Raimondi I; Jovicich J; Babiloni C; Soricelli A; Lizio R; Galluzzi S; Cavaliere L; Didic M; Schönknecht P; Molinuevo JL; Nobili F; Parnetti L; Payoux P; Bocchio L; Salvatore M; Rossini PM; Tsolaki M; Visser PJ; Richardson JC; Wiltfang J; Bordet R; Blin O; Forloni G; Frisoni GB;
    J Alzheimers Dis; 2019; 69(1):37-48. PubMed ID: 30149449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Free and Cued Selective Reminding Test and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment.
    Giuffrè GM; Quaranta D; Citro S; Morganti TG; Martellacci N; Vita MG; Rossini PM; Calabresi P; Marra C
    J Alzheimers Dis; 2024; 100(2):713-723. PubMed ID: 38905044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Plasma Biomarkers Combined with Structural MRI to Identify Candidate Participants for Alzheimer's Disease-Modifying Therapy.
    Manjavong M; Kang JM; Diaz A; Ashford MT; Eichenbaum J; Aaronson A; Miller MJ; Mackin S; Tank R; Weiner M; Nosheny R
    J Prev Alzheimers Dis; 2024; 11(5):1198-1205. PubMed ID: 39350364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer's disease.
    Leitão MJ; Silva-Spínola A; Santana I; Olmedo V; Nadal A; Le Bastard N; Baldeiras I
    Alzheimers Res Ther; 2019 Nov; 11(1):91. PubMed ID: 31759396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer's pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform.
    Martínez-Dubarbie F; Guerra-Ruiz A; López-García S; Lage C; Fernández-Matarrubia M; Infante J; Pozueta-Cantudo A; García-Martínez M; Corrales-Pardo A; Bravo M; López-Hoyos M; Irure-Ventura J; Sánchez-Juan P; García-Unzueta MT; Rodríguez-Rodríguez E
    Alzheimers Res Ther; 2023 Oct; 15(1):163. PubMed ID: 37784138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF Aβ
    Rizzi L; Maria Portal M; Batista CEA; Missiaggia L; Roriz-Cruz M
    Brain Res; 2018 Jan; 1678():27-31. PubMed ID: 29017912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA.
    Quaresima V; Pilotto A; Trasciatti C; Tolassi C; Parigi M; Bertoli D; Mordenti C; Galli A; Rizzardi A; Caratozzolo S; Benussi A; Ashton NJ; Blennow K; Zetterberg H; Giliani S; Brugnoni D; Padovani A
    Neurobiol Aging; 2024 Nov; 143():30-40. PubMed ID: 39208716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of core Biomarkers of Alzheimer's disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform.
    Agnello L; Giglio RV; Del Ben F; Piccoli T; Colletti T; Scazzone C; Lo Sasso B; Ciaccio AM; Gambino CM; Salemi G; Ciaccio M
    Sci Rep; 2024 Jul; 14(1):16084. PubMed ID: 38992063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease.
    Shi Y; Lu X; Zhang L; Shu H; Gu L; Wang Z; Gao L; Zhu J; Zhang H; Zhou D; Zhang Z
    ACS Chem Neurosci; 2019 Aug; 10(8):3479-3485. PubMed ID: 31145586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Accuracy of Blood-Derived Biomarkers for Amyloid-β Brain Deposition Along with the Alzheimer's Disease Continuum: A Systematic Review.
    Cianflone A; Coppola L; Mirabelli P; Salvatore M
    J Alzheimers Dis; 2021; 84(1):393-407. PubMed ID: 34542072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of plasma pTau
    Arranz J; Zhu N; Rubio-Guerra S; Rodríguez-Baz Í; Ferrer R; Carmona-Iragui M; Barroeta I; Illán-Gala I; Santos-Santos M; Fortea J; Lleó A; Tondo M; Alcolea D
    Alzheimers Res Ther; 2024 Jun; 16(1):139. PubMed ID: 38926773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of time of the day at sampling on CSF and plasma levels of Alzheimer' disease biomarkers.
    Orduña Dolado A; Stomrud E; Ashton NJ; Nilsson J; Quijano-Rubio C; Jethwa A; Brum WS; Brinkmalm Westman A; Zetterberg H; Blennow K; Janelidze S; Hansson O
    Alzheimers Res Ther; 2024 Jun; 16(1):132. PubMed ID: 38909218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid.
    Jia L; Qiu Q; Zhang H; Chu L; Du Y; Zhang J; Zhou C; Liang F; Shi S; Wang S; Qin W; Wang Q; Li F; Wang Q; Li Y; Shen L; Wei Y; Jia J
    Alzheimers Dement; 2019 Aug; 15(8):1071-1080. PubMed ID: 31422798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease.
    Wilson EN; Young CB; Ramos Benitez J; Swarovski MS; Feinstein I; Vandijck M; Le Guen Y; Kasireddy NM; Shahid M; Corso NK; Wang Q; Kennedy G; Trelle AN; Lind B; Channappa D; Belnap M; Ramirez V; Skylar-Scott I; Younes K; Yutsis MV; Le Bastard N; Quinn JF; van Dyck CH; Nairn A; Fredericks CA; Tian L; Kerchner GA; Montine TJ; Sha SJ; Davidzon G; Henderson VW; Longo FM; Greicius MD; Wagner AD; Wyss-Coray T; Poston KL; Mormino EC; Andreasson KI
    Alzheimers Res Ther; 2022 Nov; 14(1):172. PubMed ID: 36371232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans.
    Moon S; Kim S; Mankhong S; Choi SH; Vandijck M; Kostanjevecki V; Jeong JH; Yoon SJ; Park KW; Kim EJ; Yoon B; Kim HJ; Jang JW; Hong JY; Park DH; Shaw LM; Kang JH
    Alzheimers Res Ther; 2021 Jan; 13(1):22. PubMed ID: 33436035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
    Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
    Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.